酵素結合免疫吸着検定法(ELISA法)検査の世界市場2023年-2027年

◆英語タイトル:Global Enzyme-linked Immunosorbent Assay (Elisa) Testing Market 2023-2027

Technavioが発行した調査報告書(IRTNTR41149-23)◆商品コード:IRTNTR41149-23
◆発行会社(リサーチ会社):Technavio
◆発行日:2023年1月5日
◆ページ数:178
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:北米、ヨーロッパ、アジア、その他の地域
◆産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥370,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD4,000 ⇒換算¥592,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Technavio社の市場調査では、世界の酵素結合免疫吸着検定法(ELISA法)検査市場規模が2022年から2027年の間に564.97百万ドルへ成長し、予測期間中に年平均13.6%拡大すると予測されています。本調査書では、酵素結合免疫吸着検定法(ELISA法)検査の世界市場を広く調査・分析し、エグゼクティブサマリー、市場状況、市場規模・予測、過去の市場規模、ファイブフォース分析、用途別(ワクチン開発、免疫学、診断薬、薬物モニタリング・製薬、その他)分析、エンドユーザー別(病院・診断センター、研究所、その他)分析、顧客状況、地域別(北米、ヨーロッパ、アジア、その他地域、アメリカ、中国、イギリス、ドイツ、日本)分析、成長要因・課題・動向、企業状況、企業分析などの項目を掲載しています。なお、本書に記載されている企業情報には、Abbott Laboratories, Abcam plc, Agilent Technologies Inc., Amgen Inc., Avantor Inc., Becton Dickinson and Co., Bio Rad Laboratories Inc., bioMerieux SA, Cardinal Health Inc., Crux Biolabs Pty Ltd., Danaher Corp., Eppendorf SE, Illumina Inc., Lonza Group Ltd., Merck KGaA, Novo Nordisk AS, Perkin Elmer Inc, QIAGEN NV, Siemens Healthineers AG, Thermo Fisher Scientific Inc.などが含まれています。
・エグゼクティブサマリー
・市場状況
・市場規模・予測
・過去の市場規模
・ファイブフォース分析
・世界の酵素結合免疫吸着検定法(ELISA法)検査市場規模:用途別
- ワクチン開発における市場規模
- 免疫学における市場規模
- 診断薬における市場規模
- 薬物モニタリング・製薬における市場規模
- その他用途における市場規模
・世界の酵素結合免疫吸着検定法(ELISA法)検査市場規模:エンドユーザー別
- 病院・診断センターにおける市場規模
- 研究所における市場規模
- その他エンドユーザーにおける市場規模
・顧客状況
・世界の酵素結合免疫吸着検定法(ELISA法)検査市場規模:地域別
- 北米の酵素結合免疫吸着検定法(ELISA法)検査市場
- ヨーロッパの酵素結合免疫吸着検定法(ELISA法)検査市場
- アジアの酵素結合免疫吸着検定法(ELISA法)検査市場
- その他地域の酵素結合免疫吸着検定法(ELISA法)検査市場
- アメリカの酵素結合免疫吸着検定法(ELISA法)検査市場
- 中国の酵素結合免疫吸着検定法(ELISA法)検査市場
- イギリスの酵素結合免疫吸着検定法(ELISA法)検査市場
- ドイツの酵素結合免疫吸着検定法(ELISA法)検査市場
- 日本の酵素結合免疫吸着検定法(ELISA法)検査市場
・成長要因・課題・動向
・企業状況
・企業分析

Technavio社は、利益、価格、競争、プロモーションなどの肝要な変数の分析により、多種の情報源からのデータを調査、統合、および総括することにより、市場の詳細な全体像を提供します。また、主要産業のインフルエンサーを限定することにより、市場の様々な側面を提示します。提示されたデータは包括的​​で信頼性が高く、一次および二次の広範な調査の結果です。Technavio社の市場調査書は、正確な市場の成長を推測するための定性的および定量的調査を使用し、完全な競争状況と詳細なベンダー選定手法と分析を提供します。

酵素結合免疫吸着検定法(ELISA法)検査の世界市場 2023-2027

Technavio社は、酵素結合免疫吸着検定法(ELISA法)検査市場をモニターしており、2022年から2027年にかけて564.97百万ドルの成長が予測され、予測期間中のCAGRは13.6%で加速すると予測しています。当レポートでは、酵素結合免疫吸着検定法(ELISA法)検査市場について、市場規模や予測、動向、成長促進要因、課題などの全体的な分析に加え、約25のベンダーを網羅したベンダー分析も掲載しています。

当レポートでは、現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供します。高齢化に伴う頻繁な診断検査ニーズの高まり、食品産業における毒性検査の増加、慢性疾患の増加などが市場を牽引しています。

Technavioの酵素結合免疫吸着検定法(ELISA法)検査市場は以下のように区分されます:

・用途別:
- ワクチン開発
- 免疫学
- 診断薬
- 医薬品モニタリング・製薬産業
- その他

・エンドユーザー別:
- 病院・診断センター
- 研究所
- その他

・地域別:
- 北米
- ヨーロッパ
- アジア
- その他の地域(ROW)

本調査では、今後数年間における酵素結合免疫吸着検定法(ELISA法)検査市場の成長を促進する主な要因の一つとして、プロモーション活動の重要性の高まりを挙げています。また、がん患者の増加と新たな疾患ターゲットの出現は、市場の大きな需要につながるでしょう。

Technavio社は、複数の情報源からのデータを調査、合成、要約し、主要パラメータの分析によって、市場の詳細な姿を提示します。

当レポートでは、酵素結合免疫吸着検定法(ELISA法)検査市場について、以下の分野をカバーしています:
- 酵素結合免疫吸着検定法(ELISA法)検査市場のサイジング
- 酵素結合免疫吸着検定法(ELISA法)検査市場予測
- 酵素結合免疫吸着検定法(ELISA法)検査市場産業分析

Technavio社の確実なベンダー分析は、クライアントが市場でのポジションを向上できるように設計されており、これに沿って本レポートには、Abbott Laboratories, Abcam plc, Agilent Technologies Inc., Amgen Inc., Avantor Inc., Becton Dickinson and Co., Bio Rad Laboratories Inc., bioMerieux SA, Cardinal Health Inc., Crux Biolabs Pty Ltd., Danaher Corp., Eppendorf SE, Illumina Inc., Lonza Group Ltd., Merck KGaA, Novo Nordisk AS, Perkin Elmer Inc, QIAGEN NV, Siemens Healthineers AG, and Thermo Fisher Scientific Incなどの企業情報が含まれています。また、酵素結合免疫吸着検定法(ELISA法)検査市場の分析レポートには、市場成長に影響を与える今後の動向や課題に関する情報も含まれています。これは、企業が戦略を立て、来るべき成長機会をすべて活用するのに役立つものです。

本調査は、業界の主要参加者からのインプットを含め、一次情報と二次情報を客観的に組み合わせて実施しました。本レポートでは、主要ベンダーの分析に加え、包括的な市場およびベンダーの状況を掲載しています。

Technavio社は、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数の情報源からのデータを調査、合成、要約することにより、市場の詳細な姿を提示します。主要な業界インフルエンサーを特定することで、市場の様々な側面を提示します。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。

Technavioの市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、質的・量的調査を用いた綿密なベンダー選定方法と分析を提供します。

❖ レポートの目次 ❖

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary – Chart on Market Overview
o Exhibit 02: Executive Summary – Data Table on Market Overview
o Exhibit 03: Executive Summary – Chart on Global Market Characteristics
o Exhibit 04: Executive Summary – Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary – Chart on Market Segmentation by Application
o Exhibit 06: Executive Summary – Chart on Market Segmentation by End-user
o Exhibit 07: Executive Summary – Chart on Incremental Growth
o Exhibit 08: Executive Summary – Data Table on Incremental Growth
o Exhibit 09: Executive Summary – Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 14: Chart on Global – Market size and forecast 2022-2027 ($ million)
o Exhibit 15: Data Table on Global – Market size and forecast 2022-2027 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• 4 Historic Market Size
o 4.1 Global enzyme-linked immunosorbent assay (Elisa) testing market 2017 – 2021
o Exhibit 18: Historic Market Size – Data Table on Global enzyme-linked immunosorbent assay (Elisa) testing market 2017 – 2021 ($ million)
o 4.2 Application Segment Analysis 2017 – 2021
o Exhibit 19: Historic Market Size – Application Segment 2017 – 2021 ($ million)
o 4.3 End User Segment Analysis 2017 – 2021
o Exhibit 20: Historic Market Size – End User Segment 2017 – 2021 ($ million)
o 4.4 Geography Segment Analysis 2017 – 2021
o Exhibit 21: Historic Market Size – Geography Segment 2017 – 2021 ($ million)
o 4.5 Country Segment Analysis 2017 – 2021
o Exhibit 22: Historic Market Size – Country Segment 2017 – 2021 ($ million)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis – Comparison between 2022 and 2027
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027
o 5.7 Market condition
o Exhibit 29: Chart on Market condition – Five forces 2022 and 2027
• 6 Market Segmentation by Application
o 6.1 Market segments
o Exhibit 30: Chart on Application – Market share 2022-2027 (%)
o Exhibit 31: Data Table on Application – Market share 2022-2027 (%)
o 6.2 Comparison by Application
o Exhibit 32: Chart on Comparison by Application
o Exhibit 33: Data Table on Comparison by Application
o 6.3 Vaccine development – Market size and forecast 2022-2027
o Exhibit 34: Chart on Vaccine development – Market size and forecast 2022-2027 ($ million)
o Exhibit 35: Data Table on Vaccine development – Market size and forecast 2022-2027 ($ million)
o Exhibit 36: Chart on Vaccine development – Year-over-year growth 2022-2027 (%)
o Exhibit 37: Data Table on Vaccine development – Year-over-year growth 2022-2027 (%)
o 6.4 Immunology – Market size and forecast 2022-2027
o Exhibit 38: Chart on Immunology – Market size and forecast 2022-2027 ($ million)
o Exhibit 39: Data Table on Immunology – Market size and forecast 2022-2027 ($ million)
o Exhibit 40: Chart on Immunology – Year-over-year growth 2022-2027 (%)
o Exhibit 41: Data Table on Immunology – Year-over-year growth 2022-2027 (%)
o 6.5 Diagnostics – Market size and forecast 2022-2027
o Exhibit 42: Chart on Diagnostics – Market size and forecast 2022-2027 ($ million)
o Exhibit 43: Data Table on Diagnostics – Market size and forecast 2022-2027 ($ million)
o Exhibit 44: Chart on Diagnostics – Year-over-year growth 2022-2027 (%)
o Exhibit 45: Data Table on Diagnostics – Year-over-year growth 2022-2027 (%)
o 6.6 Drug monitoring and pharmaceutical industry – Market size and forecast 2022-2027
o Exhibit 46: Chart on Drug monitoring and pharmaceutical industry – Market size and forecast 2022-2027 ($ million)
o Exhibit 47: Data Table on Drug monitoring and pharmaceutical industry – Market size and forecast 2022-2027 ($ million)
o Exhibit 48: Chart on Drug monitoring and pharmaceutical industry – Year-over-year growth 2022-2027 (%)
o Exhibit 49: Data Table on Drug monitoring and pharmaceutical industry – Year-over-year growth 2022-2027 (%)
o 6.7 Others – Market size and forecast 2022-2027
o Exhibit 50: Chart on Others – Market size and forecast 2022-2027 ($ million)
o Exhibit 51: Data Table on Others – Market size and forecast 2022-2027 ($ million)
o Exhibit 52: Chart on Others – Year-over-year growth 2022-2027 (%)
o Exhibit 53: Data Table on Others – Year-over-year growth 2022-2027 (%)
o 6.8 Market opportunity by Application
o Exhibit 54: Market opportunity by Application ($ million)
• 7 Market Segmentation by End-user
o 7.1 Market segments
o Exhibit 55: Chart on End-user – Market share 2022-2027 (%)
o Exhibit 56: Data Table on End-user – Market share 2022-2027 (%)
o 7.2 Comparison by End-user
o Exhibit 57: Chart on Comparison by End-user
o Exhibit 58: Data Table on Comparison by End-user
o 7.3 Hospitals and diagnostic centers – Market size and forecast 2022-2027
o Exhibit 59: Chart on Hospitals and diagnostic centers – Market size and forecast 2022-2027 ($ million)
o Exhibit 60: Data Table on Hospitals and diagnostic centers – Market size and forecast 2022-2027 ($ million)
o Exhibit 61: Chart on Hospitals and diagnostic centers – Year-over-year growth 2022-2027 (%)
o Exhibit 62: Data Table on Hospitals and diagnostic centers – Year-over-year growth 2022-2027 (%)
o 7.4 Research laboratories – Market size and forecast 2022-2027
o Exhibit 63: Chart on Research laboratories – Market size and forecast 2022-2027 ($ million)
o Exhibit 64: Data Table on Research laboratories – Market size and forecast 2022-2027 ($ million)
o Exhibit 65: Chart on Research laboratories – Year-over-year growth 2022-2027 (%)
o Exhibit 66: Data Table on Research laboratories – Year-over-year growth 2022-2027 (%)
o 7.5 Others – Market size and forecast 2022-2027
o Exhibit 67: Chart on Others – Market size and forecast 2022-2027 ($ million)
o Exhibit 68: Data Table on Others – Market size and forecast 2022-2027 ($ million)
o Exhibit 69: Chart on Others – Year-over-year growth 2022-2027 (%)
o Exhibit 70: Data Table on Others – Year-over-year growth 2022-2027 (%)
o 7.6 Market opportunity by End-user
o Exhibit 71: Market opportunity by End-user ($ million)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 72: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 73: Chart on Market share By Geographical Landscape 2022-2027 (%)
o Exhibit 74: Data Table on Market share By Geographical Landscape 2022-2027 (%)
o 9.2 Geographic comparison
o Exhibit 75: Chart on Geographic comparison
o Exhibit 76: Data Table on Geographic comparison
o 9.3 North America – Market size and forecast 2022-2027
o Exhibit 77: Chart on North America – Market size and forecast 2022-2027 ($ million)
o Exhibit 78: Data Table on North America – Market size and forecast 2022-2027 ($ million)
o Exhibit 79: Chart on North America – Year-over-year growth 2022-2027 (%)
o Exhibit 80: Data Table on North America – Year-over-year growth 2022-2027 (%)
o 9.4 Europe – Market size and forecast 2022-2027
o Exhibit 81: Chart on Europe – Market size and forecast 2022-2027 ($ million)
o Exhibit 82: Data Table on Europe – Market size and forecast 2022-2027 ($ million)
o Exhibit 83: Chart on Europe – Year-over-year growth 2022-2027 (%)
o Exhibit 84: Data Table on Europe – Year-over-year growth 2022-2027 (%)
o 9.5 Asia – Market size and forecast 2022-2027
o Exhibit 85: Chart on Asia – Market size and forecast 2022-2027 ($ million)
o Exhibit 86: Data Table on Asia – Market size and forecast 2022-2027 ($ million)
o Exhibit 87: Chart on Asia – Year-over-year growth 2022-2027 (%)
o Exhibit 88: Data Table on Asia – Year-over-year growth 2022-2027 (%)
o 9.6 Rest of World (ROW) – Market size and forecast 2022-2027
o Exhibit 89: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
o Exhibit 90: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
o Exhibit 91: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o Exhibit 92: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o 9.7 US – Market size and forecast 2022-2027
o Exhibit 93: Chart on US – Market size and forecast 2022-2027 ($ million)
o Exhibit 94: Data Table on US – Market size and forecast 2022-2027 ($ million)
o Exhibit 95: Chart on US – Year-over-year growth 2022-2027 (%)
o Exhibit 96: Data Table on US – Year-over-year growth 2022-2027 (%)
o 9.8 China – Market size and forecast 2022-2027
o Exhibit 97: Chart on China – Market size and forecast 2022-2027 ($ million)
o Exhibit 98: Data Table on China – Market size and forecast 2022-2027 ($ million)
o Exhibit 99: Chart on China – Year-over-year growth 2022-2027 (%)
o Exhibit 100: Data Table on China – Year-over-year growth 2022-2027 (%)
o 9.9 UK – Market size and forecast 2022-2027
o Exhibit 101: Chart on UK – Market size and forecast 2022-2027 ($ million)
o Exhibit 102: Data Table on UK – Market size and forecast 2022-2027 ($ million)
o Exhibit 103: Chart on UK – Year-over-year growth 2022-2027 (%)
o Exhibit 104: Data Table on UK – Year-over-year growth 2022-2027 (%)
o 9.10 Germany – Market size and forecast 2022-2027
o Exhibit 105: Chart on Germany – Market size and forecast 2022-2027 ($ million)
o Exhibit 106: Data Table on Germany – Market size and forecast 2022-2027 ($ million)
o Exhibit 107: Chart on Germany – Year-over-year growth 2022-2027 (%)
o Exhibit 108: Data Table on Germany – Year-over-year growth 2022-2027 (%)
o 9.11 Japan – Market size and forecast 2022-2027
o Exhibit 109: Chart on Japan – Market size and forecast 2022-2027 ($ million)
o Exhibit 110: Data Table on Japan – Market size and forecast 2022-2027 ($ million)
o Exhibit 111: Chart on Japan – Year-over-year growth 2022-2027 (%)
o Exhibit 112: Data Table on Japan – Year-over-year growth 2022-2027 (%)
o 9.12 Market opportunity By Geographical Landscape
o Exhibit 113: Market opportunity By Geographical Landscape ($ million)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 114: Impact of drivers and challenges in 2022 and 2027
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 115: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 116: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 117: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 118: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 119: Matrix on vendor position and classification
o 12.3 Abbott Laboratories
o Exhibit 120: Abbott Laboratories – Overview
o Exhibit 121: Abbott Laboratories – Business segments
o Exhibit 122: Abbott Laboratories – Key news
o Exhibit 123: Abbott Laboratories – Key offerings
o Exhibit 124: Abbott Laboratories – Segment focus
o 12.4 Abcam plc
o Exhibit 125: Abcam plc – Overview
o Exhibit 126: Abcam plc – Product / Service
o Exhibit 127: Abcam plc – Key news
o Exhibit 128: Abcam plc – Key offerings
o 12.5 Agilent Technologies Inc.
o Exhibit 129: Agilent Technologies Inc. – Overview
o Exhibit 130: Agilent Technologies Inc. – Business segments
o Exhibit 131: Agilent Technologies Inc. – Key news
o Exhibit 132: Agilent Technologies Inc. – Key offerings
o Exhibit 133: Agilent Technologies Inc. – Segment focus
o 12.6 Avantor Inc.
o Exhibit 134: Avantor Inc. – Overview
o Exhibit 135: Avantor Inc. – Business segments
o Exhibit 136: Avantor Inc. – Key offerings
o Exhibit 137: Avantor Inc. – Segment focus
o 12.7 Becton Dickinson and Co.
o Exhibit 138: Becton Dickinson and Co. – Overview
o Exhibit 139: Becton Dickinson and Co. – Business segments
o Exhibit 140: Becton Dickinson and Co. – Key news
o Exhibit 141: Becton Dickinson and Co. – Key offerings
o Exhibit 142: Becton Dickinson and Co. – Segment focus
o 12.8 Bio Rad Laboratories Inc.
o Exhibit 143: Bio Rad Laboratories Inc. – Overview
o Exhibit 144: Bio Rad Laboratories Inc. – Business segments
o Exhibit 145: Bio Rad Laboratories Inc. – Key news
o Exhibit 146: Bio Rad Laboratories Inc. – Key offerings
o Exhibit 147: Bio Rad Laboratories Inc. – Segment focus
o 12.9 bioMerieux SA
o Exhibit 148: bioMerieux SA – Overview
o Exhibit 149: bioMerieux SA – Product / Service
o Exhibit 150: bioMerieux SA – Key offerings
o 12.10 Danaher Corp.
o Exhibit 151: Danaher Corp. – Overview
o Exhibit 152: Danaher Corp. – Business segments
o Exhibit 153: Danaher Corp. – Key news
o Exhibit 154: Danaher Corp. – Key offerings
o Exhibit 155: Danaher Corp. – Segment focus
o 12.11 Eppendorf SE
o Exhibit 156: Eppendorf SE – Overview
o Exhibit 157: Eppendorf SE – Product / Service
o Exhibit 158: Eppendorf SE – Key news
o Exhibit 159: Eppendorf SE – Key offerings
o 12.12 Merck KGaA
o Exhibit 160: Merck KGaA – Overview
o Exhibit 161: Merck KGaA – Business segments
o Exhibit 162: Merck KGaA – Key news
o Exhibit 163: Merck KGaA – Key offerings
o Exhibit 164: Merck KGaA – Segment focus
o 12.13 Novo Nordisk AS
o Exhibit 165: Novo Nordisk AS – Overview
o Exhibit 166: Novo Nordisk AS – Business segments
o Exhibit 167: Novo Nordisk AS – Key offerings
o Exhibit 168: Novo Nordisk AS – Segment focus
o 12.14 Perkin Elmer Inc
o Exhibit 169: Perkin Elmer Inc – Overview
o Exhibit 170: Perkin Elmer Inc – Business segments
o Exhibit 171: Perkin Elmer Inc – Key news
o Exhibit 172: Perkin Elmer Inc – Key offerings
o Exhibit 173: Perkin Elmer Inc – Segment focus
o 12.15 QIAGEN NV
o Exhibit 174: QIAGEN NV – Overview
o Exhibit 175: QIAGEN NV – Product / Service
o Exhibit 176: QIAGEN NV – Key news
o Exhibit 177: QIAGEN NV – Key offerings
o 12.16 Siemens Healthineers AG
o Exhibit 178: Siemens Healthineers AG – Overview
o Exhibit 179: Siemens Healthineers AG – Business segments
o Exhibit 180: Siemens Healthineers AG – Key news
o Exhibit 181: Siemens Healthineers AG – Key offerings
o Exhibit 182: Siemens Healthineers AG – Segment focus
o 12.17 Thermo Fisher Scientific Inc.
o Exhibit 183: Thermo Fisher Scientific Inc. – Overview
o Exhibit 184: Thermo Fisher Scientific Inc. – Business segments
o Exhibit 185: Thermo Fisher Scientific Inc. – Key news
o Exhibit 186: Thermo Fisher Scientific Inc. – Key offerings
o Exhibit 187: Thermo Fisher Scientific Inc. – Segment focus
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 188: Inclusions checklist
o Exhibit 189: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 190: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 191: Research methodology
o Exhibit 192: Validation techniques employed for market sizing
o Exhibit 193: Information sources
o 13.5 List of abbreviations
o Exhibit 194: List of abbreviations

Exhibits:
Exhibits1: Executive Summary – Chart on Market Overview
Exhibits2: Executive Summary – Data Table on Market Overview
Exhibits3: Executive Summary – Chart on Global Market Characteristics
Exhibits4: Executive Summary – Chart on Market By Geographical Landscape
Exhibits5: Executive Summary – Chart on Market Segmentation by Application
Exhibits6: Executive Summary – Chart on Market Segmentation by End-user
Exhibits7: Executive Summary – Chart on Incremental Growth
Exhibits8: Executive Summary – Data Table on Incremental Growth
Exhibits9: Executive Summary – Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global – Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global – Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size – Data Table on Global enzyme-linked immunosorbent assay (Elisa) testing market 2017 – 2021 ($ million)
Exhibits19: Historic Market Size – Application Segment 2017 – 2021 ($ million)
Exhibits20: Historic Market Size – End User Segment 2017 – 2021 ($ million)
Exhibits21: Historic Market Size – Geography Segment 2017 – 2021 ($ million)
Exhibits22: Historic Market Size – Country Segment 2017 – 2021 ($ million)
Exhibits23: Five forces analysis – Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants – Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes – Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry – Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition – Five forces 2022 and 2027
Exhibits30: Chart on Application – Market share 2022-2027 (%)
Exhibits31: Data Table on Application – Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Application
Exhibits33: Data Table on Comparison by Application
Exhibits34: Chart on Vaccine development – Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on Vaccine development – Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on Vaccine development – Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Vaccine development – Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Immunology – Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on Immunology – Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on Immunology – Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Immunology – Year-over-year growth 2022-2027 (%)
Exhibits42: Chart on Diagnostics – Market size and forecast 2022-2027 ($ million)
Exhibits43: Data Table on Diagnostics – Market size and forecast 2022-2027 ($ million)
Exhibits44: Chart on Diagnostics – Year-over-year growth 2022-2027 (%)
Exhibits45: Data Table on Diagnostics – Year-over-year growth 2022-2027 (%)
Exhibits46: Chart on Drug monitoring and pharmaceutical industry – Market size and forecast 2022-2027 ($ million)
Exhibits47: Data Table on Drug monitoring and pharmaceutical industry – Market size and forecast 2022-2027 ($ million)
Exhibits48: Chart on Drug monitoring and pharmaceutical industry – Year-over-year growth 2022-2027 (%)
Exhibits49: Data Table on Drug monitoring and pharmaceutical industry – Year-over-year growth 2022-2027 (%)
Exhibits50: Chart on Others – Market size and forecast 2022-2027 ($ million)
Exhibits51: Data Table on Others – Market size and forecast 2022-2027 ($ million)
Exhibits52: Chart on Others – Year-over-year growth 2022-2027 (%)
Exhibits53: Data Table on Others – Year-over-year growth 2022-2027 (%)
Exhibits54: Market opportunity by Application ($ million)
Exhibits55: Chart on End-user – Market share 2022-2027 (%)
Exhibits56: Data Table on End-user – Market share 2022-2027 (%)
Exhibits57: Chart on Comparison by End-user
Exhibits58: Data Table on Comparison by End-user
Exhibits59: Chart on Hospitals and diagnostic centers – Market size and forecast 2022-2027 ($ million)
Exhibits60: Data Table on Hospitals and diagnostic centers – Market size and forecast 2022-2027 ($ million)
Exhibits61: Chart on Hospitals and diagnostic centers – Year-over-year growth 2022-2027 (%)
Exhibits62: Data Table on Hospitals and diagnostic centers – Year-over-year growth 2022-2027 (%)
Exhibits63: Chart on Research laboratories – Market size and forecast 2022-2027 ($ million)
Exhibits64: Data Table on Research laboratories – Market size and forecast 2022-2027 ($ million)
Exhibits65: Chart on Research laboratories – Year-over-year growth 2022-2027 (%)
Exhibits66: Data Table on Research laboratories – Year-over-year growth 2022-2027 (%)
Exhibits67: Chart on Others – Market size and forecast 2022-2027 ($ million)
Exhibits68: Data Table on Others – Market size and forecast 2022-2027 ($ million)
Exhibits69: Chart on Others – Year-over-year growth 2022-2027 (%)
Exhibits70: Data Table on Others – Year-over-year growth 2022-2027 (%)
Exhibits71: Market opportunity by End-user ($ million)
Exhibits72: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits73: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits74: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits75: Chart on Geographic comparison
Exhibits76: Data Table on Geographic comparison
Exhibits77: Chart on North America – Market size and forecast 2022-2027 ($ million)
Exhibits78: Data Table on North America – Market size and forecast 2022-2027 ($ million)
Exhibits79: Chart on North America – Year-over-year growth 2022-2027 (%)
Exhibits80: Data Table on North America – Year-over-year growth 2022-2027 (%)
Exhibits81: Chart on Europe – Market size and forecast 2022-2027 ($ million)
Exhibits82: Data Table on Europe – Market size and forecast 2022-2027 ($ million)
Exhibits83: Chart on Europe – Year-over-year growth 2022-2027 (%)
Exhibits84: Data Table on Europe – Year-over-year growth 2022-2027 (%)
Exhibits85: Chart on Asia – Market size and forecast 2022-2027 ($ million)
Exhibits86: Data Table on Asia – Market size and forecast 2022-2027 ($ million)
Exhibits87: Chart on Asia – Year-over-year growth 2022-2027 (%)
Exhibits88: Data Table on Asia – Year-over-year growth 2022-2027 (%)
Exhibits89: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
Exhibits90: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
Exhibits91: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits92: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits93: Chart on US – Market size and forecast 2022-2027 ($ million)
Exhibits94: Data Table on US – Market size and forecast 2022-2027 ($ million)
Exhibits95: Chart on US – Year-over-year growth 2022-2027 (%)
Exhibits96: Data Table on US – Year-over-year growth 2022-2027 (%)
Exhibits97: Chart on China – Market size and forecast 2022-2027 ($ million)
Exhibits98: Data Table on China – Market size and forecast 2022-2027 ($ million)
Exhibits99: Chart on China – Year-over-year growth 2022-2027 (%)
Exhibits100: Data Table on China – Year-over-year growth 2022-2027 (%)
Exhibits101: Chart on UK – Market size and forecast 2022-2027 ($ million)
Exhibits102: Data Table on UK – Market size and forecast 2022-2027 ($ million)
Exhibits103: Chart on UK – Year-over-year growth 2022-2027 (%)
Exhibits104: Data Table on UK – Year-over-year growth 2022-2027 (%)
Exhibits105: Chart on Germany – Market size and forecast 2022-2027 ($ million)
Exhibits106: Data Table on Germany – Market size and forecast 2022-2027 ($ million)
Exhibits107: Chart on Germany – Year-over-year growth 2022-2027 (%)
Exhibits108: Data Table on Germany – Year-over-year growth 2022-2027 (%)
Exhibits109: Chart on Japan – Market size and forecast 2022-2027 ($ million)
Exhibits110: Data Table on Japan – Market size and forecast 2022-2027 ($ million)
Exhibits111: Chart on Japan – Year-over-year growth 2022-2027 (%)
Exhibits112: Data Table on Japan – Year-over-year growth 2022-2027 (%)
Exhibits113: Market opportunity By Geographical Landscape ($ million)
Exhibits114: Impact of drivers and challenges in 2022 and 2027
Exhibits115: Overview on Criticality of inputs and Factors of differentiation
Exhibits116: Overview on factors of disruption
Exhibits117: Impact of key risks on business
Exhibits118: Vendors covered
Exhibits119: Matrix on vendor position and classification
Exhibits120: Abbott Laboratories – Overview
Exhibits121: Abbott Laboratories – Business segments
Exhibits122: Abbott Laboratories – Key news
Exhibits123: Abbott Laboratories – Key offerings
Exhibits124: Abbott Laboratories – Segment focus
Exhibits125: Abcam plc – Overview
Exhibits126: Abcam plc – Product / Service
Exhibits127: Abcam plc – Key news
Exhibits128: Abcam plc – Key offerings
Exhibits129: Agilent Technologies Inc. – Overview
Exhibits130: Agilent Technologies Inc. – Business segments
Exhibits131: Agilent Technologies Inc. – Key news
Exhibits132: Agilent Technologies Inc. – Key offerings
Exhibits133: Agilent Technologies Inc. – Segment focus
Exhibits134: Avantor Inc. – Overview
Exhibits135: Avantor Inc. – Business segments
Exhibits136: Avantor Inc. – Key offerings
Exhibits137: Avantor Inc. – Segment focus
Exhibits138: Becton Dickinson and Co. – Overview
Exhibits139: Becton Dickinson and Co. – Business segments
Exhibits140: Becton Dickinson and Co. – Key news
Exhibits141: Becton Dickinson and Co. – Key offerings
Exhibits142: Becton Dickinson and Co. – Segment focus
Exhibits143: Bio Rad Laboratories Inc. – Overview
Exhibits144: Bio Rad Laboratories Inc. – Business segments
Exhibits145: Bio Rad Laboratories Inc. – Key news
Exhibits146: Bio Rad Laboratories Inc. – Key offerings
Exhibits147: Bio Rad Laboratories Inc. – Segment focus
Exhibits148: bioMerieux SA – Overview
Exhibits149: bioMerieux SA – Product / Service
Exhibits150: bioMerieux SA – Key offerings
Exhibits151: Danaher Corp. – Overview
Exhibits152: Danaher Corp. – Business segments
Exhibits153: Danaher Corp. – Key news
Exhibits154: Danaher Corp. – Key offerings
Exhibits155: Danaher Corp. – Segment focus
Exhibits156: Eppendorf SE – Overview
Exhibits157: Eppendorf SE – Product / Service
Exhibits158: Eppendorf SE – Key news
Exhibits159: Eppendorf SE – Key offerings
Exhibits160: Merck KGaA – Overview
Exhibits161: Merck KGaA – Business segments
Exhibits162: Merck KGaA – Key news
Exhibits163: Merck KGaA – Key offerings
Exhibits164: Merck KGaA – Segment focus
Exhibits165: Novo Nordisk AS – Overview
Exhibits166: Novo Nordisk AS – Business segments
Exhibits167: Novo Nordisk AS – Key offerings
Exhibits168: Novo Nordisk AS – Segment focus
Exhibits169: Perkin Elmer Inc – Overview
Exhibits170: Perkin Elmer Inc – Business segments
Exhibits171: Perkin Elmer Inc – Key news
Exhibits172: Perkin Elmer Inc – Key offerings
Exhibits173: Perkin Elmer Inc – Segment focus
Exhibits174: QIAGEN NV – Overview
Exhibits175: QIAGEN NV – Product / Service
Exhibits176: QIAGEN NV – Key news
Exhibits177: QIAGEN NV – Key offerings
Exhibits178: Siemens Healthineers AG – Overview
Exhibits179: Siemens Healthineers AG – Business segments
Exhibits180: Siemens Healthineers AG – Key news
Exhibits181: Siemens Healthineers AG – Key offerings
Exhibits182: Siemens Healthineers AG – Segment focus
Exhibits183: Thermo Fisher Scientific Inc. – Overview
Exhibits184: Thermo Fisher Scientific Inc. – Business segments
Exhibits185: Thermo Fisher Scientific Inc. – Key news
Exhibits186: Thermo Fisher Scientific Inc. – Key offerings
Exhibits187: Thermo Fisher Scientific Inc. – Segment focus
Exhibits188: Inclusions checklist
Exhibits189: Exclusions checklist
Exhibits190: Currency conversion rates for US$
Exhibits191: Research methodology
Exhibits192: Validation techniques employed for market sizing
Exhibits193: Information sources
Exhibits194: List of abbreviations



❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 酵素結合免疫吸着検定法(ELISA法)検査の世界市場2023年-2027年(Global Enzyme-linked Immunosorbent Assay (Elisa) Testing Market 2023-2027)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆